BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shan X, Gong X, Li J, Wen J, Li Y, Zhang Z. Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Khawar MB, Afzal A, Abbasi MH, Sheikh N, Sun H. Nano-immunoengineering of CAR-T cell therapy against tumor microenvironment: The way forward in combating cancer. OpenNano 2023;10:100124. [DOI: 10.1016/j.onano.2023.100124] [Reference Citation Analysis]
2 Wu Y, Xie H, Li Y, Bao X, Lu GL, Wen J, Gao Y, Li Y, Zhang Z. Nitric Oxide-Loaded Bioinspired Lipoprotein Normalizes Tumor Vessels To Improve Intratumor Delivery and Chemotherapy of Albumin-Bound Paclitaxel Nanoparticles. Nano Lett 2023;23:939-47. [PMID: 36701555 DOI: 10.1021/acs.nanolett.2c04312] [Reference Citation Analysis]
3 Tan P, Chen X, Zhang H, Wei Q, Luo K. Artificial intelligence aids in development of nanomedicines for cancer management. Semin Cancer Biol 2023;89:61-75. [PMID: 36682438 DOI: 10.1016/j.semcancer.2023.01.005] [Reference Citation Analysis]
4 Lilia Romero E, Jose Morilla M. Ether lipids from archaeas in nano-drug delivery and vaccination. Int J Pharm 2023;:122632. [PMID: 36690132 DOI: 10.1016/j.ijpharm.2023.122632] [Reference Citation Analysis]
5 Placci M, Giannotti MI, Muro S. Polymer-Based Drug Delivery Systems Under Investigation For Enzyme Replacement And Other Therapies Of Lysosomal Storage Disorders. Adv Drug Deliv Rev 2023;:114683. [PMID: 36657645 DOI: 10.1016/j.addr.2022.114683] [Reference Citation Analysis]
6 Dong N, Liu Z, He H, Lu Y, Qi J, Wu W. "Hook&Loop" multivalent interactions based on disk-shaped nanoparticles strengthen active targeting. J Control Release 2023;354:279-93. [PMID: 36641117 DOI: 10.1016/j.jconrel.2023.01.022] [Reference Citation Analysis]
7 Marques AC, Costa PC, Velho S, Amaral MH. Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 2023;15. [PMID: 36678845 DOI: 10.3390/pharmaceutics15010216] [Reference Citation Analysis]
8 Thapa RK, Kim JO. Nanomedicine-based commercial formulations: current developments and future prospects. J Pharm Investig 2023;53:19-33. [PMID: 36568502 DOI: 10.1007/s40005-022-00607-6] [Reference Citation Analysis]
9 Dri DA, Rinaldi F, Carafa M, Marianecci C. Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes. Drug Deliv Transl Res 2023;13:757-69. [PMID: 36450964 DOI: 10.1007/s13346-022-01262-y] [Reference Citation Analysis]
10 Salazar J, Carmona T, Zacconi FC, Venegas-Yazigi D, Cabello-Verrugio C, Il Choi W, Vilos C. The Human Dermis as a Target of Nanoparticles for Treating Skin Conditions. Pharmaceutics 2022;15. [PMID: 36678639 DOI: 10.3390/pharmaceutics15010010] [Reference Citation Analysis]
11 Menon I, Zaroudi M, Zhang Y, Aisenbrey E, Hui L. Fabrication of active targeting lipid nanoparticles: Challenges and perspectives. Materials Today Advances 2022;16:100299. [DOI: 10.1016/j.mtadv.2022.100299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Yedgar S, Barshtein G, Gural A. Hemolytic Activity of Nanoparticles as a Marker of Their Hemocompatibility. Micromachines (Basel) 2022;13. [PMID: 36557391 DOI: 10.3390/mi13122091] [Reference Citation Analysis]
13 Zhang W, Jiang Y, He Y, Boucetta H, Wu J, Chen Z, He W. Lipid carriers for mRNA delivery. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.026] [Reference Citation Analysis]
14 Hermosillo-ochoa E, Cortez-lemus NA, Rivero-espejel I, Reynoso-soto EA. RAFT-mediated polymerization-induced self-assembly of cholic acid-derived monomer. J Polym Res 2022;29. [DOI: 10.1007/s10965-022-03260-7] [Reference Citation Analysis]
15 Lopes J, Rodrigues CMP, Gaspar MM, Reis CP. Melanoma Management: From Epidemiology to Treatment and Latest Advances. Cancers 2022;14:4652. [DOI: 10.3390/cancers14194652] [Reference Citation Analysis]
16 Grifoni L, Vanti G, Donato R, Sacco C, Bilia AR. Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities. Molecules 2022;27:6070. [PMID: 36144803 DOI: 10.3390/molecules27186070] [Reference Citation Analysis]
17 Scariot DB, Staneviciute A, Zhu J, Li X, Scott EA, Engman DM. Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases? Front Cell Infect Microbiol 2022;12:1000972. [DOI: 10.3389/fcimb.2022.1000972] [Reference Citation Analysis]
18 Ghasemiyeh P, Mohammadi-samani S, Noorizadeh K, Zadmehr O, Rasekh S, Mohammadi-samani S, Dehghan D. Novel topical drug delivery systems in acne management: Molecular mechanisms and role of targeted delivery systems for better therapeutic outcomes. Journal of Drug Delivery Science and Technology 2022;74:103595. [DOI: 10.1016/j.jddst.2022.103595] [Reference Citation Analysis]
19 Han R, Xiao Y, Bai Q, Jonathan Choi CH. Self-therapeutic metal-based nanoparticles for treating inflammatory diseases. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Oliveira C, Ferreira CJO, Sousa M, Paris JL, Gaspar R, Silva BFB, Teixeira JA, Ferreira-santos P, Botelho CM. A Versatile Nanocarrier—Cubosomes, Characterization, and Applications. Nanomaterials 2022;12:2224. [DOI: 10.3390/nano12132224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ma X, Li SJ, Liu Y, Zhang T, Xue P, Kang Y, Sun ZJ, Xu Z. Bioengineered nanogels for cancer immunotherapy. Chem Soc Rev 2022;51:5136-74. [PMID: 35666131 DOI: 10.1039/d2cs00247g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
22 Haist M, Mailänder V, Bros M. Nanodrugs Targeting T Cells in Tumor Therapy. Front Immunol 2022;13:912594. [PMID: 35693776 DOI: 10.3389/fimmu.2022.912594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ahmed T, Liu FF, Lu B, Lip H, Park E, Alradwan I, Liu JF, He C, Zetrini A, Zhang T, Ghavaminejad A, Rauth AM, Henderson JT, Wu XY. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs. Mol Pharm 2022. [PMID: 35587783 DOI: 10.1021/acs.molpharmaceut.2c00038] [Reference Citation Analysis]
24 Qian X, Xu X, Wu Y, Wang J, Li J, Chen S, Wen J, Li Y, Zhang Z. Strategies of engineering nanomedicines for tumor retention. J Control Release 2022:S0168-3659(22)00200-0. [PMID: 35447297 DOI: 10.1016/j.jconrel.2022.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]